Pivalate

Pivalate

SCHEMBL6237077

CC(C)(C)C(=O)O.CN(C)CCC[C@](O)(c1ccc(F)cc1)c1ccc(C#N)cc1CO

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 2/20 0.40
BCL2 P10415 8/20 0.37
SLC6A2 P23975 2/20 0.35
HTR2C P28335 2/20 0.35
ADRA1A P35348 2/20 0.35
HRH1 P35367 2/20 0.35
OPRM1 P35372 2/20 0.35
DRD3 P35462 2/20 0.35
HTR2B P41595 2/20 0.35
KCNH2 Q12809 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
SLC22A1 O15245 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pivalate SCHEMBL27604130 1.00 SLC6A4 (0.40) SLC6A4MAPK1LMNABCL2SLC6A2
Acetic Acid SCHEMBL27702816 0.94 SLC6A4 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
Oxalic Acid SCHEMBL21808124 0.94 SLC6A4 (0.44) SLC6A4MAPK1LMNABCL2SLC6A2
Acetic Acid SCHEMBL27702815 0.94 SLC6A4 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL1362860 0.93 SLC6A4 (0.40) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL29414619 0.93 BCL2 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL29414628 0.93 BCL2 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL679 0.93 BCL2 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL907577 0.93 BCL2 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2
SCHEMBL907571 0.93 BCL2 (0.42) SLC6A4MAPK1LMNABCL2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534654-A1 METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM H. LUNDBECK A/S (DK) 2005-06-01 EP disclosed
WO-2004014821-A1 METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM H. LUNDBECK A/S (DK) 2004-02-19 WO disclosed